Literature DB >> 15939034

Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.

Sven Christoph Beutelspacher1, Navid Ardjomand, Peng Hong Tan, Gillian Sarah Patton, D Frank P Larkin, Andrew J T George, Myra O McClure.   

Abstract

In this study we compare the ability of self-inactivating Human Immunodeficiency Virus 1 (HIV-1) and Equine Infectious Anaemia Virus (EIAV)-based vectors to mediate gene transfer to rabbit and human corneas and to a murine corneal endothelial cell line. Both vectors were pseudotyped with vesicular stomatitis virus-G (VSV-G) envelope and contained marker transgenes under the control of an internal CMV promoter. For specificity of action, the heterologous promoter in the EIAV-vector was exchanged for an inducible E-Selectin promoter, previously shown to regulate gene-expression in a plasmid system. We show that EIAV is more efficient than HIV in transducing human and rabbit corneal endothelial cells. Rabbit corneal endothelial cells are transduced in higher quantity than human corneal endothelial cells. In the inducible system, however, we detected impairment between the vector and its internal E-Selectin promoter. Instead of controlled transgene expression or silencing of promoter activity, the U3-modified long-terminal-repeats (LTR) impaired the conditional activity of the E-Selectin promoter. Significant transgene expression was seen without stimulation of the inducible promoter. We show efficient transduction by lentiviruses of a corneal endothelial cell line and of full thickness corneas from different species, confirming that those vectors would be appropriate tools for gene therapy of selected corneal diseases. However, the modification within the U3-LTR did not adequately allow regulated transgene expression. These findings have important implications for vector design for diagnostic or therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939034     DOI: 10.1016/j.exer.2004.12.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  12 in total

Review 1.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

2.  Efficient transduction of cytotoxic and anti-HIV-1 genes by a gene-regulatable lentiviral vector.

Authors:  Yasuhiko Shinoda; Kuniko Hieda; Yoshio Koyanagi; Youichi Suzuki
Journal:  Virus Genes       Date:  2009-10       Impact factor: 2.332

3.  Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage.

Authors:  T A Fuchsluger; U Jurkunas; A Kazlauskas; R Dana
Journal:  Gene Ther       Date:  2011-03-17       Impact factor: 5.250

Review 4.  Corneal gene therapy: basic science and translational perspective.

Authors:  Rajiv R Mohan; Jason T Rodier; Ajay Sharma
Journal:  Ocul Surf       Date:  2013-02-13       Impact factor: 5.033

5.  [Comparison of several viral vectors for gene therapy of corneal endothelial cells].

Authors:  S C Beutelspacher; N Serbecic; P Tan; M O McClure
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

6.  Corneal endothelial cells are protected from apoptosis by gene therapy.

Authors:  Thomas A Fuchsluger; Ula Jurkunas; Andrius Kazlauskas; Reza Dana
Journal:  Hum Gene Ther       Date:  2011-03-17       Impact factor: 5.695

7.  VIP and VIP gene silencing modulation of differentiation marker N-cadherin and cell shape of corneal endothelium in human corneas ex vivo.

Authors:  Shay-Whey M Koh; Krish Chandrasekara; Cara J Abbondandolo; Timothy J Coll; Allan R Rutzen
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-25       Impact factor: 4.799

8.  Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells.

Authors:  Christoph Engler; Clare Kelliher; Karl J Wahlin; Caroline L Speck; Albert S Jun
Journal:  Mol Vis       Date:  2009-04-01       Impact factor: 2.367

9.  Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition.

Authors:  Adnan Khan; Hongmei Fu; Lee Aun Tan; Jennifer E Harper; Sven C Beutelspacher; Daniel F P Larkin; Giovanna Lombardi; Myra O McClure; Andrew J T George
Journal:  Eur J Immunol       Date:  2013-01-18       Impact factor: 5.532

10.  Overexpression of a mutant form of TGFBI/BIGH3 induces retinal degeneration in transgenic mice.

Authors:  Mauro Bustamante; Andrea Tasinato; Fabienne Maurer; Ilhem Elkochairi; Mario G Lepore; Yvan Arsenijevic; Thierry Pedrazzini; Francis L Munier; Daniel F Schorderet
Journal:  Mol Vis       Date:  2008-06-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.